These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Tang GW; Lo SS Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588 [TBL] [Abstract][Full Text] [Related]
9. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148 [TBL] [Abstract][Full Text] [Related]
10. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
11. Canadian Contraception Consensus (Part 1 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N; J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [TBL] [Abstract][Full Text] [Related]
12. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Milsom I; Andersson K; Andersch B; Rybo G Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665 [TBL] [Abstract][Full Text] [Related]
13. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908 [TBL] [Abstract][Full Text] [Related]
14. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Bahamondes L; Valeria Bahamondes M; Shulman LP Hum Reprod Update; 2015; 21(5):640-51. PubMed ID: 26037216 [TBL] [Abstract][Full Text] [Related]
15. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Lethaby A; Hussain M; Rishworth JR; Rees MC Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648 [TBL] [Abstract][Full Text] [Related]
16. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Backman T Drug Saf; 2004; 27(15):1185-204. PubMed ID: 15588115 [TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine system: uses and controversies. Bahamondes L; Bahamondes MV; Monteiro I Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044 [TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS. Bednarek PH; Jensen JT Int J Womens Health; 2010 Aug; 1():45-58. PubMed ID: 21072274 [TBL] [Abstract][Full Text] [Related]
19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]